ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Rimsys and QualiZeal Announce Strategic Partnership for Quality Engineering Transformation

QualiZeal to provide Test Advisory, Quality Engineering, Test Automation and Quality Governance & Management services to Rimsys

QualiZeal, a leading Digital Quality Engineering services company, announced strategic long-term partnership with Pittsburgh-based Rimsys, the leading and only holistic RIM software for MedTech. Rimsys has chosen QualiZeal to help enable their desire to build superior quality products and enhance customer experience.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220531005685/en/

QualiZeal and Rimsys Team (Photo: Business Wire)

QualiZeal and Rimsys Team (Photo: Business Wire)

Through this engagement, QualiZeal will work with Rimsys to establish a world class Quality Engineering organization to help Rimsys deliver superior products with a faster time to market.

Brady Ryba, CTO & Co-Founder, Rimsys – “RIM (Regulatory Information Management) software systems are becoming increasingly necessary as more and more countries adopt specific market entrance requirements and the global regulatory landscape becomes increasingly complex. This leaves MedTech regulatory professionals on the front lines, responsible for correctly deciphering entrance requirements and coordinating the assembly of complex submission documents. QualiZeal shares our quality vision & values and brings in delivery excellence, quality engineering expertise and willingness to walk extra mile for mutual success. I am sure that this partnership will enrich our customer experience and product quality.”

Kote Bipilli, SVP – Client Success, QualiZeal, said, “We are delighted to be have been selected as the Quality Engineering partner to help Rimsys, the leading holistic RIM software provider, in their digital journey. Leveraging our Global delivery model, Quality Engineering offerings and Assets & Platforms we are committed to drive excellence in transforming their software testing methodology, test organization maturity and user experience of the products.”

About Rimsys

Rimsys is on a mission to bring regulatory order to the MedTech industry. The Rimsys Regulatory Information Management (RIM) platform digitizes and automates regulatory activities, freeing teams from inefficient administrative work, and helping them confidently establish and secure global regulatory compliance. Unlike complex, color-coded spreadsheets, or expensive external consultants, Rimsys seamlessly centralizes all regulatory information, automates submission processes, and monitors relevant expirations, standards, and global regulations. Traditional approaches to regulatory affairs can’t keep pace with the growing complexity of the global landscape, and overburdened teams face increasing compliance risks. Rimsys streamlines all regulatory activities including registrations, essential principles, UDI, standards management, and regulatory intelligence in a single, integrated platform. Leading global MedTech companies including Johnson & Johnson, Siemens Healthiness, and Omron rely on Rimsys to get new products to market more quickly, and reduce revenue risk of non-compliance, product recalls, and unexpected expirations. For more information, visit www.rimsys.io.

About QualiZeal

QualiZeal is a trusted partner for end-to-end, Quality Engineering solutions and services for the digital world. We help our clients tackle quality engineering challenges through our innovative solutions that will help them to harness technological changes and gain a competitive advantage. For more information, visit www.qualizeal.com.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  223.07
+0.53 (0.24%)
AAPL  275.05
+0.94 (0.34%)
AMD  209.22
+1.64 (0.79%)
BAC  55.01
-0.32 (-0.59%)
GOOG  307.40
-1.92 (-0.62%)
META  660.57
+13.06 (2.02%)
MSFT  476.88
+2.06 (0.43%)
NVDA  177.45
+1.16 (0.66%)
ORCL  189.40
+4.48 (2.42%)
TSLA  489.29
+13.98 (2.94%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.